Recombinant interferon alfa-2a in advanc
β
G. R. C. McLeod; D. B. Thomson; P. Hersey
π
Article
π
1987
π
John Wiley and Sons
π
French
β 384 KB
There is a rising incidence of malignant melanoma world-wide and, despite major improvements in i t s early diagnosis and treatment, the 10-year death rate remains at 20-25%. Evidence that the immune system has a role in the control of melanoma growth has encouraged immunological intervention. The r